Lyme Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People
Condition:   Lyme Disease Interventions:   Biological: 2217LS Fully Human Monoclonal Antibody;   Other: Placebo Comparator (0.9% NaCl) Sponsors:   MassBiologics;   Celerion Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2021 Category: Research Source Type: clinical trials

First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People
Condition:   Lyme Disease Interventions:   Biological: 2217LS;   Other: 0.9% Sodium Chloride (NaCl) Sponsors:   MassBiologics;   Celerion Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2021 Category: Research Source Type: clinical trials